McCormick & Co. Inc. (MKC) Falls 3.34% for January 19

Equities Staff |

One of the S&P 500’s big losers for Tuesday January 19 was McCormick & Co. Inc. (MKC). The company’s stock fell 3.34% to $80.91 on volume of 984,922 shares.

The stock opened the day at 82.50 and traded between a low of $80.80 and a high of $82.80. The stock finished the day down $2.8 per share. McCormick & Co. Inc. has an average daily volume of 733,480 and a total float of 128.05 million shares. The 50-day SMA for McCormick & Co. Inc. is $84.67 and its 200-day SMA is $80.58. The high for the stock over the last 52 weeks is $87.46 and the low is $70.70.

McCormick & Company Inc manufactures, markets and distributes spices, seasoning mixes, condiments and other flavorful products to the entire food industryretail outlets, food manufacturers and foodservice businesses.

McCormick & Co. Inc. is centered in Sparks, MD, and has 10,000 employees. Today’s trading day leaves the company with a market cap of $10.36 billionwith a P/E Ratio of 27.1. The company has a P/S ratio of 3.46, P/B ratio of 5.94, and a -90.8.

For a complete fundamental analysis analysis of McCormick & Co. Inc., check out’s Stock Valuation Analysis report for MKC. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…